Last Action | 04/08/22: signed by Governor (Acts Ch. 154) |
---|---|
Title | AN ACT relating to opioid antagonists designed to reverse the effects of an opioid overdose. |
Bill Documents |
Acts Chapter 154
Current/Final Introduced |
Bill Request Number | 187 |
Sponsors | D. Douglas, R. Alvarado |
Summary of Original Version | Amend KRS 15.291, 217.177, and 217.186 to define "opioid antagonist" as naloxone or any United States Food and Drug Administration-approved opioid antagonist designed to reverse the effects of an opioid overdose; replace references to naloxone with opiod antagonist. |
Index Headings of Original Version |
Drugs and Medicines - Opioid antagonist, overdose reversal Health and Medical Services - Opioid antagonist, overdose reversal Pharmacists - Opioid antagonist, overdose reversal Physicians and Practitioners - Opioid antagonist, overdose reversal Substance Abuse - Opioid antagonist, overdose reversal Opioids - Opioid antagonist, overdose reversal |
Jump to Proposed Amendments | Senate Floor Amendment 1 |
Votes | Vote History |
01/06/22 |
|
---|---|
01/10/22 |
|
01/12/22 |
|
01/13/22 |
|
01/18/22 |
|
01/19/22 |
|
01/20/22 |
|
03/09/22 |
|
03/17/22 |
|
03/18/22 |
|
03/22/22 |
|
03/29/22 |
|
03/30/22 |
|
04/08/22 |
|
Amendment | Senate Floor Amendment 1 |
---|---|
Sponsor | D. Douglas |
Summary | Retain original provisions of the bill; add provisions for providing an opioid antagonist as part of a harm reduction program; make technical corrections. |
Index Headings |
Drugs and Medicines - Opioid antagonist, overdose reversal Health and Medical Services - Opioid antagonist, overdose reversal Pharmacists - Opioid antagonist, overdose reversal Physicians and Practitioners - Opioid antagonist, overdose reversal Substance Abuse - Opioid antagonist, overdose reversal Opioids - Opioid antagonist, overdose reversal |
Last updated: 2/8/2023 2:57 PM (EST)